The FDA has granted Fast Track designation to ABBV-CLS-628 for the treatment of autosomal dominant polycystic kidney disease.
Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, today announced the U.S. Food and Drug ...
Premanand Ji Maharaj, a revered spiritual leader from Vrindavan, has been living with complete kidney failure for nearly two ...
- Food and Drug Administration granted Breakthrough Therapy Designation for povetacicept in IgA nephropathy; on track to file for accelerated approval in the U.S. in H1 2026 if 36-week interim ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important advancements across its programs in immunoglobulin A Nephropathy (IgAN), APOL1-mediated kidney disease (AMKD) and ...
AbbVie (ABBV) stock is in focus as a kidney disease therapy developed by the company and its partner Calico wins the FDA Fast Track Designation. Read more here.
A video of a Muslim man is currently going viral on social media, touching the hearts of devotees of Premanand Maharaj and ...
A family is calling for urgent action after a father with a kidney disease died after developing sepsis. Reading resident Gareth Prodger, who lived with autosomal dominant polycystic kidney disease ...